Effectiveness of Cannabis in the Treatment of Tinnitus Patients

Wolfson Medical Center (WMC)

Status and phase: Withdrawn; Phase 1

Conditions: Tinnitus

Treatments: Drug: Cannabis; Drug: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT01969474

1.01

Details and patient eligibility

About

The hypothesis of the study is that the use of Cannabis will attenuate the tinnitus level as experienced by the patients.

Sex: All

Ages: 30+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Tinnitus lasting more than 3 months
• Tinnitus Handicap Inventory score over 58
• Treated previously for tinnitus (2 modalities)

Exclusion criteria

• Prior use of drugs
• Current use of Cannabis
• Neurologic or Psychiatric disease
• Heart Failure
• Ischemic Heart Disease
• Immune Deficiency
• Acoustic Neuroma

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

0 participants in 2 patient groups, including a placebo group

Cannabis

Experimental group

Description:

Treatment with a Cannabis capsule

Treatment:

Drug: Cannabis

Placebo

Placebo Comparator group

Description:

Placebo

Treatment:

Drug: Placebo